176 related articles for article (PubMed ID: 32453002)
1. Novel therapies for advanced urologic cancers.
Heidenreich A
Curr Opin Urol; 2020 Jul; 30(4):594-601. PubMed ID: 32453002
[TBL] [Abstract][Full Text] [Related]
2. Cancer immunotherapy: new applications in urologic oncology.
Mullane SA; Bellmunt J
Curr Opin Urol; 2016 Nov; 26(6):556-63. PubMed ID: 27584023
[TBL] [Abstract][Full Text] [Related]
3. Cancer immunotherapy: new applications in urologic oncology.
Hurwitz ME; Sokhn J; Petrylak DP
Curr Opin Urol; 2016 Nov; 26(6):535-42. PubMed ID: 27584025
[TBL] [Abstract][Full Text] [Related]
4. Developments in urologic oncology 'OncoForum': The best of 2014.
Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
Actas Urol Esp; 2015 Jun; 39(5):271-8. PubMed ID: 25770399
[TBL] [Abstract][Full Text] [Related]
5. Treatment of bone metastases in urologic malignancies.
Froehner M; Hölscher T; Hakenberg OW; Wirth MP
Urol Int; 2014; 93(3):249-56. PubMed ID: 25115989
[TBL] [Abstract][Full Text] [Related]
6. Developments in urologic oncology «OncoForum»: The best of 2015.
Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
Actas Urol Esp; 2016; 40(6):361-9. PubMed ID: 27061663
[TBL] [Abstract][Full Text] [Related]
7. What's new in urology.
Williams RD
J Am Coll Surg; 2002 Nov; 195(5):663-74. PubMed ID: 12437254
[No Abstract] [Full Text] [Related]
8. [Interferon therapy in urology].
Kriegmair M; Hofstetter A
Urologe A; 1989 Mar; 28(2):116-21. PubMed ID: 2470188
[TBL] [Abstract][Full Text] [Related]
9. Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?
Tonyali S; Yazici S
Int Urol Nephrol; 2016 May; 48(5):671-80. PubMed ID: 26843415
[TBL] [Abstract][Full Text] [Related]
10. Immune gene therapy in urology.
Kausch I; Ardelt P; Böhle A; Ratliff TL
Curr Urol Rep; 2002 Feb; 3(1):82-9. PubMed ID: 12084224
[TBL] [Abstract][Full Text] [Related]
11. Potential role for metformin in urologic oncology.
Sayyid RK; Fleshner NE
Investig Clin Urol; 2016 May; 57(3):157-64. PubMed ID: 27195314
[TBL] [Abstract][Full Text] [Related]
12. Pathomics in urology.
Schuettfort VM; Pradere B; Rink M; Comperat E; Shariat SF
Curr Opin Urol; 2020 Nov; 30(6):823-831. PubMed ID: 32881725
[TBL] [Abstract][Full Text] [Related]
13. Highlights from the Society of Urologic Oncology, 5th Annual Meeting, December 3-4, 2004, Bethesda, Maryland, United States of America.
Grubb RL; Behari A; Kim CM; Williams CR; Linehan WM; Coleman JA
J Urol; 2005 Dec; 174(6):2330-3. PubMed ID: 16280834
[TBL] [Abstract][Full Text] [Related]
14. Is there an emerging role for neoadjuvant targeted therapy in renal cell carcinoma?
Maruschke M; Hakenberg OW
Minerva Urol Nefrol; 2009 Jun; 61(2):109-14. PubMed ID: 19451892
[TBL] [Abstract][Full Text] [Related]
15. Perioperative approaches to kidney cancer.
Iheanacho K; Vaishampayan U
Clin Adv Hematol Oncol; 2020 Jan; 18(1):56-65. PubMed ID: 32511222
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy in kidney cancer: the past, present, and future.
Hammers H
Curr Opin Urol; 2016 Nov; 26(6):543-7. PubMed ID: 27533501
[TBL] [Abstract][Full Text] [Related]
17. Evolving Treatment of Advanced Urothelial Cancer.
Sridhar SS
J Oncol Pract; 2017 May; 13(5):309-315. PubMed ID: 28489981
[TBL] [Abstract][Full Text] [Related]
18. Strategies for the management of recurrent and advanced urologic cancers. Quality of life.
Herr HW
Cancer; 1987 Aug; 60(3 Suppl):623-30. PubMed ID: 3297289
[TBL] [Abstract][Full Text] [Related]
19. Current Landscape of Advanced and Metastatic Renal Cell Carcinoma Management.
Huang WC; Becher E
Urol Clin North Am; 2020 Aug; 47(3):xiii-xiv. PubMed ID: 32600542
[No Abstract] [Full Text] [Related]
20. Systemic Therapy for Advanced Urothelial Carcinoma: Current Standards and Treatment Considerations.
Dietrich B; Siefker-Radtke AO; Srinivas S; Yu EY
Am Soc Clin Oncol Educ Book; 2018 May; 38():342-353. PubMed ID: 30231356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
